Literature DB >> 28266513

Prostate cancer: Targeting metabolism.

Louise Stone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28266513     DOI： 10.1038/nrurol.2017.34

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer.

Authors:  Jianneng Li; Mohammad Alyamani; Ao Zhang; Kai-Hsiung Chang; Michael Berk; Zhenfei Li; Ziqi Zhu; Marianne Petro; Cristina Magi-Galluzzi; Mary-Ellen Taplin; Jorge A Garcia; Kevin Courtney; Eric A Klein; Nima Sharifi
Journal:  Elife       Date:  2017-02-13       Impact factor: 8.140
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.